GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson’s Disease and Neuropathic Pain

GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson’s Disease and Neuropathic Pain

GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson’s Disease and Neuropathic Pain LAS VEGAS, Dec. 5, 2019 /PRNewswire/ — GB Sciences, Inc....